WILMINGTON, Del., Jan. 30, 2017 -- Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Oregon on behalf of holders of Lattice Semiconductor Corporation (“Lattice”) (NASDAQ GS:LSCC) common stock in connection with the proposed acquisition of Lattice by Canyon Bridge Capital Partners, Inc. and its affiliates (collectively, “Canyon Bridge”) announced on November 3, 2016 (the “Complaint”). The Complaint, which alleges violations of the Securities Exchange Act of 1934 against Lattice, its Board of Directors (the “Board”), and Canyon Bridge, is captioned Parshall v. Lattice Semiconductor Corp., Case No. 3:17-cv-00035-SI (D. Or.).
If you wish to discuss this action or have any questions concerning this notice or your rights or interests, please contact plaintiff’s counsel, Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 2 Righter Parkway, Suite 120, Wilmington, DE 19803, by telephone at (888) 969-4242; by e-mail at [email protected]; or at: http://rigrodskylong.com/investigations/lattice-semiconductor-corporation-lscc/.
On November 3, 2016, Lattice entered into an agreement and plan of merger (the “Merger Agreement”) with Canyon Bridge. Pursuant to the Merger Agreement, Lattice shareholders will receive $8.30 per share in cash (the “Proposed Transaction”).
The Complaint alleges that, in an attempt to secure shareholder support for the Proposed Transaction, on December 28, 2016, defendants issued materially incomplete disclosures in a Preliminary Proxy Statement (the “Proxy Statement”) filed with the United States Securities and Exchange Commission. The Complaint asserts that the Proxy Statement, which recommends that Lattice stockholders vote in favor of the Proposed Transaction, omitted material information necessary to enable shareholders to make an informed decision as to how to vote on the Proposed Transaction, including material information with respect to Lattice’s financial projections, the opinions and analyses of Lattice’s financial advisor, and the background of the Proposed Transaction. The Complaint seeks injunctive and equitable relief and damages on behalf of holders of Lattice common stock.
If you wish to serve as lead plaintiff, you must move the Court no later than March 31, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. Any member of the proposed class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.
Rigrodsky & Long, P.A., with offices in Wilmington, Delaware and Garden City, New York, regularly prosecutes securities class, derivative and direct actions, shareholder rights litigation, and corporate governance litigation, on behalf of shareholders in states and federal courts throughout the United States.
Attorney advertising. Prior results do not guarantee a similar outcome.
CONTACT: Rigrodsky & Long, P.A. Seth D. Rigrodsky Gina M. Serra (888) 969-4242 (302) 295-5310 Fax: (302) 654-7530 [email protected] http://www.rigrodskylong.com


Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 



